-
1 Comment
SSY Group Limited is currently in a long term uptrend where the price is trading 65.0% above its 200 day moving average.
From a valuation standpoint, the stock is 97.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.2.
SSY Group Limited's total revenue rose by 7.3% to $2B since the same quarter in the previous year.
Its net income has dropped by 37.9% to $365M since the same quarter in the previous year.
Finally, its free cash flow grew by 109.4% to $55M since the same quarter in the previous year.
Based on the above factors, SSY Group Limited gets an overall score of 4/5.
| Exchange | HK |
|---|---|
| CurrencyCode | HKD |
| ISIN | KYG8406X1034 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Beta | 0.63 |
|---|---|
| PE Ratio | 8.08 |
| Market Cap | 9B |
| Dividend Yield | 6.0% |
| Target Price | 5.1267 |
SSY Group Limited, an investment holding company, research, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; food, beverages, and catering businesses; and production and sale of methylamine. It sells its products under the Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was founded in 1999 and is headquartered in Wan Chai, Hong Kong.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2005.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
